In the realm of modern neuroscience, few figures embody the convergence of personal narrative and scientific innovation as compellingly as Dr. Dilek Colak. Her journey from the rural outskirts of Sakarya, Turkey, to leading a cutting-edge laboratory at Weill Cornell Medicine has been as remarkable as the insights emerging from her research. Dr. Colak’s work delves deep into the molecular intricacies of brain function, focusing on the enigmatic roles of glial cells—particularly astrocytes—and how disruptions in their activity might underpin devastating neurodevelopmental and neuropsychiatric disorders.
Glial cells, once relegated to the sidelines of neuroscience, have surged to the forefront thanks to pioneering work such as Dr. Colak’s. Her laboratory investigates how these cells, excluded from traditional neuron-centric models, possess multifaceted functions essential to brain development and homeostasis. By employing human stem cell-derived brain organoids—a miniature, simplified version of the human brain—the research transcends rodent models, offering unprecedented molecular resolution into human-specific pathways. This approach reveals the dynamic RNA degradation processes and local protein synthesis within astrocytes that may unravel the cellular origins of diseases like autism and schizophrenia.
Dr. Colak’s scientific odyssey is rooted in an uncompromising curiosity sparked by a childhood memory: a boy on a balcony isolated by mental illness. This early observation planted the seed for what would become a lifelong quest to decipher the biological underpinnings of neuropsychiatric conditions. After completing her doctoral research on cellular brain development at Munich’s Helmholtz Center and the Max Planck Institute, she transitioned to molecular neuroscience during her postdoctoral work with Dr. Samie Jaffrey. Here, Dr. Colak identified an RNA-directed silencing mechanism implicated in Fragile X Syndrome, one of the most common inherited causes of intellectual disability and autism.
This discovery not only enhanced our understanding of Fragile X but also shifted her ambitions towards translational neuroscience—the bridge between bench science and clinical application. In 2015, Dr. Colak established her own laboratory, blending molecular biology with pediatric medicine through a dual appointment at the Feil Family Brain and Mind Research Institute and the Gale and Ira Drukier Institute for Children’s Health. Her team integrates genetically engineered mouse models with human organoids to create a framework for understanding how molecular defects translate to behavioral phenotypes observed in patients.
One of the most groundbreaking aspects of her current research is exploring RNA degradation pathways within astrocytes, a domain that remains under-explored despite its enormous implications. Astrocytes contribute to synaptic modulation, neuroinflammation, and neurotransmitter clearance—functions critical to maintaining neural circuitry balance. Dr. Colak’s laboratory uses advanced single-cell transcriptomics and live imaging to capture how disruptions in these pathways precipitate the neurodevelopmental cascade, potentially leading to clinical manifestations such as impaired social interaction and cognitive deficits.
Dr. Colak is vocal about the structural barriers within the scientific community that often hinder the pursuit of holistic and locally relevant research. She critiques the prevailing metrics of “scientific excellence” that disproportionately emphasize high-impact publications and narrowly defined basic science, arguing instead for broader evaluative frameworks that incorporate clinical expertise and societal relevance. This stance challenges conventional academic hierarchies and advocates for a reimagined culture in biomedical research that values qualitative impact alongside quantitative metrics.
Her personal narrative is as layered as her scientific pursuits. Overcoming systemic obstacles to achieve advanced education abroad, Dr. Colak stands as an exemplar of resilience and determination. While her heroes include trailblazing women like Malala Yousafzai, her own life intertwines the intimate and the professional seamlessly—balancing a demanding research career with family life in New Jersey. Her reflections reveal a scientist acutely aware of the temporal fragility of life and the imperative to cherish the present, encapsulated in her motto to “appreciate what you have while you work on what you want.”
The lab she leads pushes technological boundaries in neuropsychiatric research, integrating human organoids derived from pluripotent stem cells with genetically modified mice to decode complex cellular interactions. These models shed light on the “molecular signatures” of disorders such as schizophrenia and autism, providing a substrate for future targeted therapies. By dissecting how glial cells, especially astrocytes, regulate local protein synthesis and cellular communication, Dr. Colak’s work elucidates how molecular dysfunctions translate to the circuit abnormalities and behavioral phenotypes characteristic of mental illness.
Beyond the lab, Dr. Colak’s insights emphasize the necessity for science to transcend sterile experimentation and engage with the societal contexts of disease. Her pioneering investigations into glial biology not only push forward fundamental neuroscience but also strive to illuminate the path toward better diagnosis and treatment of conditions that profoundly affect children and families worldwide. As mental health challenges continue to rise globally, her research provides a beacon of hope rooted in molecular precision and clinical relevance.
Dr. Colak’s approach also calls for a paradigm shift in academic culture and research valuation. By urging the scientific community to abandon reductive impact-factor fixation in favor of holistic assessments, she champions diversity—in disciplines, perspectives, and the broader inclusion of clinical voices. This ethic not only democratizes knowledge production but also promises to accelerate innovation by aligning research priorities more closely with human needs.
The powerful fusion of personal origin story, rigorous science, and societal critique makes Dr. Dilek Colak a definitive voice in the neuroscience of mental illness. Her work underscores the imperative to integrate molecular insights with patient-centered approaches, advancing a future in which the mysteries of glial cell function could unlock treatments that currently seem out of reach. As the boy on the balcony once watched in silence, so too does her research continue to observe, decode, and ultimately transform the neuroscience of complex brain disorders.
Through her visionary leadership and groundbreaking laboratory techniques, Dr. Colak exemplifies how modern neuroscience can harness cellular biology, genetic engineering, and patient relevance to drive forward not only knowledge but also hope for those affected by neurodevelopmental and neuropsychiatric diseases. Her ongoing investigations promise to redefine our understanding of the brain’s silent architects and open novel avenues for clinical breakthroughs in pediatric neurology.
Subject of Research: People
Article Title: Dilek Colak: How do glial cells achieve multiple functions, and how do they contribute to neurodevelopmental and neuropsychiatric diseases?
News Publication Date: 5-May-2026
Web References:
Genomic Psychiatry Interview – https://doi.org/10.61373/gp026k.0030
Innovators and Ideas Series – https://interviews.genomicpress.com/
Image Credits: Dilek Colak, PhD, Weill Cornell Medicine, Cornell University, USA
Keywords: glial cells, astrocytes, RNA degradation, brain organoids, neurodevelopmental disorders, neuropsychiatric diseases, autism, schizophrenia, molecular neuroscience, stem cells, Fragile X Syndrome, neuroscience innovation
